This list is an analysis based on recent market events. It's not an investment recommendation.
About
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
What is Hansoh Pharmaceutical Group Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Hansoh Pharmaceutical Group Company Limited stocks are traded under the ticker HNPHY.
When is the next Hansoh Pharmaceutical Group Company Limited earnings date?▼
Hansoh Pharmaceutical Group Company Limited is going to release the next earnings report on March 30, 2027.
What were Hansoh Pharmaceutical Group Company Limited earnings last quarter?▼
HNPHY earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.07 USD resulting in a +42.86% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Hansoh Pharmaceutical Group Company Limited revenue for the last year?▼
Hansoh Pharmaceutical Group Company Limited revenue for the last year amounts to 2.12B USD.
What is Hansoh Pharmaceutical Group Company Limited net income for the last year?▼
HNPHY net income for the last year is 783.6M USD.
How many employees does Hansoh Pharmaceutical Group Company Limited have?▼
As of November 17, 2026, the company has 9,643 employees.
In which sector is Hansoh Pharmaceutical Group Company Limited located?▼
Hansoh Pharmaceutical Group Company Limited operates in the Health & Wellness sector.
When did Hansoh Pharmaceutical Group Company Limited complete a stock split?▼
Hansoh Pharmaceutical Group Company Limited has not had any recent stock splits.
Where is Hansoh Pharmaceutical Group Company Limited headquartered?▼
Hansoh Pharmaceutical Group Company Limited is headquartered in Shanghai, Cayman Islands.